Approval · Notice of Compliance 658 · 2002
EMLA: Notice of Compliance 658
Issued February 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 658
- Date
- February 19, 2002
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: topical analgesia on intact skin prior to vaccination with vaccines that have been shown not to interact with emla in clinical trials
- Therapeutic class
- Topical anesthetic for dermal analgesia
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMLA | Not yet assigned | — |
Medicinal ingredients
- LIDOCAINE 25 MG per G
- PRILOCAINE 25 MG per G
- LIDOCAINE 2.5 PER
- PRILOCAINE 2.5 PER